Middle East

UAE aster Novartis signs memorandum to promote digital transformation and clinical research

Based in the United Arab Emirates, AsterDM Healthcare has signed a Memorandum of Understanding (MoU) with global pharmaceutical company Novartis.

The statement states that MoU will give Aster access to Novartis’ advanced treatment platform and data science to further enhance treatment outcomes for patients in the UAE and beyond.

Collaboration focused on digital transformation and clinical research aims to identify current gaps in patient care and deploy extensive medical programs using innovative data platforms and data syndicate designs. .. This is in line with Aster’s long-term plan to integrate clinical research and digital transformation into operations in the UAE, and beyond that, it has a significant impact on providing clinical outcomes for patients.

As part of the collaboration, Novartis will enable data generation, ideas, and influential decision making for Aster DM Healthcare’s clinical research programs. The organization plans to launch a series of workshops, training, and educational activities. This will help Aster start activities related to clinical research.

The Digital Transformation Initiative will also individually work to strengthen Aster’s digital healthcare strategy for the UAE and beyond, but Novartis will provide that expertise and share best practices.

“Clinical research-focused data analysis is one of the cornerstones of future healthcare. Aster aims to stay ahead of the curve and make it possible by providing patients with the best medical solutions. We are trying to provide physicians with state-of-the-art systems. We are pleased to have partnered with Novartis in the past to form a multifaceted partnership to enhance digital transformation and research. ” Dr. Azad Moopen, Founder, Chairman and Managing Director of Aster DM Healthcare, said.

“We sincerely believe that we share a common vision and we are confident that this partnership will add value and may affect patients in the UAE. Novartis Pharmaceuticals Gulf Cluster Mohammed Ez Eldin, President and Head of the Company, said:

read: Power Letters 2022: Aster DM Healthcare, Vice President, Alisha Moopen

https://gulfbusiness.com/uaes-aster-novartis-sign-mou-to-advance-digital-transformation-clinical-research/ UAE aster Novartis signs memorandum to promote digital transformation and clinical research

Back to top button